A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 27 550 KRW 4.36%
Market Cap: 1.3T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

Intrinsic Value

ABL Bio Inc's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ABL Bio Inc stock under the Base Case scenario is 8 503.62 KRW. Compared to the current market price of 27 550 KRW, ABL Bio Inc is Overvalued by 69%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
8 503.62 KRW
Overvaluation 69%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation History
ABL Bio Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for ABL Bio Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ABL Bio Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

27 550 KRW
+4.36%
+4.36%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

ABL Bio Inc
KR
Biotechnology
Market Cap
1.3T KRW
IPO
Dec 19, 2018
Employees
90
Korea
Market Cap
1.3T KRW
Industry
Biotechnology
IPO
Dec 19, 2018
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about ABL Bio Inc

Provide an overview of the primary business activities
of ABL Bio Inc.

What unique competitive advantages
does ABL Bio Inc hold over its rivals?

What risks and challenges
does ABL Bio Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ABL Bio Inc.

Provide P/S
for ABL Bio Inc.

Provide P/E
for ABL Bio Inc.

Provide P/OCF
for ABL Bio Inc.

Provide P/FCFE
for ABL Bio Inc.

Provide P/B
for ABL Bio Inc.

Provide EV/S
for ABL Bio Inc.

Provide EV/GP
for ABL Bio Inc.

Provide EV/EBITDA
for ABL Bio Inc.

Provide EV/EBIT
for ABL Bio Inc.

Provide EV/OCF
for ABL Bio Inc.

Provide EV/FCFF
for ABL Bio Inc.

Provide EV/IC
for ABL Bio Inc.

Show me price targets
for ABL Bio Inc made by professional analysts.

What are the Revenue projections
for ABL Bio Inc?

How accurate were the past Revenue estimates
for ABL Bio Inc?

What are the Net Income projections
for ABL Bio Inc?

How accurate were the past Net Income estimates
for ABL Bio Inc?

What are the EPS projections
for ABL Bio Inc?

How accurate were the past EPS estimates
for ABL Bio Inc?

What are the EBIT projections
for ABL Bio Inc?

How accurate were the past EBIT estimates
for ABL Bio Inc?

Compare the revenue forecasts
for ABL Bio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ABL Bio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ABL Bio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of ABL Bio Inc compared to its peers.

Compare the P/E ratios
of ABL Bio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing ABL Bio Inc with its peers.

Analyze the financial leverage
of ABL Bio Inc compared to its main competitors.

Show all profitability ratios
for ABL Bio Inc.

Provide ROE
for ABL Bio Inc.

Provide ROA
for ABL Bio Inc.

Provide ROIC
for ABL Bio Inc.

Provide ROCE
for ABL Bio Inc.

Provide Gross Margin
for ABL Bio Inc.

Provide Operating Margin
for ABL Bio Inc.

Provide Net Margin
for ABL Bio Inc.

Provide FCF Margin
for ABL Bio Inc.

Show all solvency ratios
for ABL Bio Inc.

Provide D/E Ratio
for ABL Bio Inc.

Provide D/A Ratio
for ABL Bio Inc.

Provide Interest Coverage Ratio
for ABL Bio Inc.

Provide Altman Z-Score Ratio
for ABL Bio Inc.

Provide Quick Ratio
for ABL Bio Inc.

Provide Current Ratio
for ABL Bio Inc.

Provide Cash Ratio
for ABL Bio Inc.

What is the historical Revenue growth
over the last 5 years for ABL Bio Inc?

What is the historical Net Income growth
over the last 5 years for ABL Bio Inc?

What is the current Free Cash Flow
of ABL Bio Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for ABL Bio Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ABL Bio Inc

Current Assets 36.1B
Cash & Short-Term Investments 33.7B
Receivables 434.8m
Other Current Assets 2B
Non-Current Assets 84.6B
Long-Term Investments 1.7B
PP&E 79.9B
Intangibles 2.5B
Other Non-Current Assets 523.3m
Current Liabilities 23.4B
Accrued Liabilities 309.3m
Other Current Liabilities 23.1B
Non-Current Liabilities 44.2B
Long-Term Debt 43B
Other Non-Current Liabilities 1.2B
Efficiency

Earnings Waterfall
ABL Bio Inc

Revenue
24.4B KRW
Operating Expenses
-60.1B KRW
Operating Income
-35.8B KRW
Other Expenses
-141.5m KRW
Net Income
-35.9B KRW

Free Cash Flow Analysis
ABL Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

ABL Bio Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
ROIC is Increasing
Declining ROE
Negative Revenue Growth Forecast
23/100
Profitability
Score

ABL Bio Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

ABL Bio Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
50/100
Solvency
Score

ABL Bio Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
ABL Bio Inc

Wall Street analysts forecast ABL Bio Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 50 660 KRW with a low forecast of 37 370 KRW and a high forecast of 63 000 KRW.

Lowest
Price Target
37 370 KRW
36% Upside
Average
Price Target
50 660 KRW
84% Upside
Highest
Price Target
63 000 KRW
129% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ABL Bio Inc?

Click here to dive deeper.

Dividends

ABL Bio Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ABL Bio Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one ABL Bio Inc stock?

The intrinsic value of one ABL Bio Inc stock under the Base Case scenario is 8 503.62 KRW.

Is ABL Bio Inc stock undervalued or overvalued?

Compared to the current market price of 27 550 KRW, ABL Bio Inc is Overvalued by 69%.

Back to Top